Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Chiesi Limited, 333 Styal Road, Manchester, M22 5LG, UK
Depefex 150 mg XL Capsules.
| Pharmaceutical Form |
|---|
|
Prolonged-release capsules, hard. Depefex 150 mg XL Capsules are natural transparent capsules containing white or whitish pellets. |
Each prolonged release capsule contains 150 mg of venlafaxine as venlafaxine hydrochloride.
Venlafaxine is chemically defined as (R/S)1[(2-dimethylamino)1(4-methoxy phenyl) ethyl] cyclohexanol hydrochloride.
Depefex Capsules contain sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Venlafaxine |
Venlafaxine has an antidepressant effect. The mechanism of its action in humans is believed to be associated with its potentiation of neurotransmitter activity in the central nervous system. |
| List of Excipients |
|---|
|
Stearic acid Sugar spheres 20: Sucrose Capsule shell: Gelatin |
Al/PVDC – clear PVC/PVDC blister packs of 28 capsules.
Chiesi Limited, 333 Styal Road, Manchester, M22 5LG, UK
Depefex 150 mg XL Capsules: PL 8829/0172
15/02/2008 / 27/05/2018
| Drug | Countries | |
|---|---|---|
| DEPEFEX | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
